Shock, Cardiogenic
Conditions
Keywords
Shock, IVBP, ECMO, In hospital death
Brief summary
Retrospectively and prospectively enrolled patients with cardiogenic shock in domestic manifolds and investigated the current state of treatment and clinical features of cardiogenic shock in Koreans and identified the factors that could improve the prognosis and the use of IABP and ECMO And to investigate its therapeutic effect.
Detailed description
1. The selection / exclusion criteria for persons with cardiogenic shock should be verified by medical records from January 1, 2014 before the approval date of each institution's clinical trial screening committee. 2. If a cardiogenic shock to the selection criteria is found in the emergency room, general ward, or intensive care unit of the participating institutions, enroll in this study and fill in the information according to the e-CRF. 3. After 1, 6 and 12 months, visit the hospital for examination and procedures. The person in charge of the examination or the delegate of the examiner may follow the person by telephone or an outpatient visit.
Interventions
None listed
Sponsors
Jeong Hoon Yang
Study design
Observational model
COHORT
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. 19 years old or older 2. ① Systolic blood pressure is less than 90mmHg for more than 30 minutes despite the fluid therapy, or Use of pressure boosting agents is necessary. ② Peripheral hypopnea (cold skin, urine less than 30 cc per hour, impaired consciousness, lactate ≥2.0 mmol / l) or a person with pulmonary edema. 3. Causes of cardiogenic shock include acute myocardial infarction (including in coronary intervention), cardiomyopathy, myocarditis, pulmonary embolism, refractory ventricular tachycardia, shock during coronary intervention. 4. Those voluntarily consenting to the medical records and the data necessary for the study during the entire study period.
Exclusion criteria
1. Other causes except for cardiogenic shock (low blood pressure, septic, obstructive shock) 2. Shock with cardiac arrest outside the hospital 3. People with allergic reactions to anticoagulants such as heparin. 4. Those who refused active treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In hospital death | for 1 year |
Secondary
| Measure | Time frame |
|---|---|
| Death in 1 year | 1 year |
| Death, myocardial infarction, stroke, re-admission due to heart failure during follow-up. | 1 year |
| Number of days of intensive care unit Number of days of intensive care unit | 1 year |
| Death in 28days | 28days |
| Lactate 24 hour clearance | 1 year |
| Successful removal of left ventricular assist device (IABP, ECMO) | 1 year |
| hospitalization days | 1 year |
Countries
South Korea
Contacts
Primary ContactJeong Hoon Yang
Backup ContactJin Hee Seo
Outcome results
None listed